Huabang Health (002004): Foreign Investment Rating Report (FIR)
First coverage of Huabang Health (002004): Promoting multi-field business layout
Huabang Health (002004) Review: Establishing a Medical Holding Subsidiary, Big Health's Layout Is Next
Huabang Health (002004) Interim Report Review: Single-quarter performance improved, overall gross margin increased
Huabang Health (002004): quarterly increase in performance and deepening of the layout of medical services
Huabang Health (002004) Annual Report Review: “Medicine” and “Medicine” Dual Engine Drive Optimism in the Field of Rehabilitation
Comments on Huabang Health (002004) Annual report: main business growth, stable expansion of rehabilitation medicine
Comments on Huabang Health (002004) Annual report: large Health Industry accelerates expansion of agrochemical business and spin-off listing
Huabang Health (002004) in-depth report: blockbuster products are expected to expand the healthy layout is imperative
Comments on Huabang Health (002004): the main business of medicine is growing rapidly and the rehabilitation plate is ready to start.
华邦健康(002004)调研简报:主营业务高速增长 康复医疗进展顺利
华邦健康(002004)点评:拟增资生命原点 进军细胞治疗
华邦健康(002004)点评:收购生命原点、快速切入干细胞存储与应用、全力推进大健康战略
【国信证券】华邦健康:收购生命原点、快速切入干细胞存储与应用、全力推进大健康战略
华邦健康股票代码(002004)点评:投资生命原点 开启先进医疗技术领域的布局
【西南证券】华邦健康:拟增资生命原点,进军细胞治疗
【华创证券】华邦健康:投资生命原点,开启先进医疗技术领域的布局
华邦健康(002004)点评:拟收生命原点部分股权 完善健康产业链
【华泰证券】华邦健康:拟收生命原点部分股权,完善健康产业链
华邦健康(002004)点评:拟收购瑞士生物 海外布局持续推进
No Data
No Data